The CEOs of Eli Lilly and Novo Nordisk — rivals in the GLP-1 obesity market — addressed nagging questions at the 2024 J.P. Morgan Healthcare Conference.
The drug maker is promoting ‘inclusive obesity care’ with help from Queen Latifah.
A MediaRadar study found that advertising spend in the category jumped 21% in 2023.
Data show both are catching up to — and in some cases surpassing — physicians in prescribing volume for diabetes and obesity meds.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
